• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Perivalvular Leak (1457); Detachment of Device or Device Component (2907); Insufficient Information (3190)
Patient Problems Dyspnea (1816); Insufficient Information (4580)
Event Date 01/03/2023
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was learned through implant patient registry that a 23mm 11500a aortic valve was explanted after an implant duration of 4 months, 27 days due to unknown reason.The explanted valve was replaced with a 23mm 11500a valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Valve dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of an inadequate prosthetic valve implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction of the device.The most likely cause is patient factors, including reported fistula.
 
Event Description
It was learned through implant patient registry that a 23mm 11500a aortic valve was explanted after an implant duration of 4 months, 27 days due to dehiscence and paravalvular leak (pvl).The patient presented with dyspnea.The explanted valve was replaced with a 23mm 11500a valve.Per medical records, the patient presented with murmur, worsening volume overload, and dyspnea.Tee confirmed pvl along with distance of the bovine pericardial patch from the previous avr surgery.Intraoperatively, there was dehiscence of the aortic bioprosthesis from the left coronary sinus.The valve was removed.The previously sewn bovine pericardial patch had dehisced as well, with a fistula underneath the left coronary cusp to the la, that was also removed.Sutures with pledgets were placed on the ventricular side taking bite through the aorto-mitral curtain and up to the aortic annulus.The explanted valve was replaced with another 23mm 11500a valve.There was a small pvl underneath the left main.Given the complexity of the repair and the small size of the prior pvl the surgeon decided not to perform any intervention.The patient transferred out of the or in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 - office m2013
irvine, CA 92614
9492506615
MDR Report Key16325182
MDR Text Key309057950
Report Number2015691-2023-10680
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194982
UDI-Public(01)00690103194982(17)260413(11)220414219279373
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Device Catalogue Number11500A23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age54 YR
Patient SexFemale
-
-